Early research shows that MOTS-c may improve insulin sensitivity, support fat loss, boost exercise capacity, reduce inflammation, and help slow age-related muscle loss
FOXO4-DRI Safety and Side Effects: What the Evidence Shows (2026) In the published mouse studies, FOXO4-DRI caused no reported side effects: treated animals kept their weight, blood counts, and organ markers while senescent cells were cleared, and the peptide spared healthy cells in culture
Consult your healthcare professional before use if you are pregnant, breastfeeding, have a medical condition, or are taking prescribed medication
Results of these were compared with the level of antioxidant enzymes in mice following administration of crude C
At 68 weeks, participants receiving the cagrilintide-semaglutide combination achieved a mean body weight reduction of 22.7% under the trial product estimand
It is not an over-the-counter substitute for diabetes medication